Understanding triple-negative breast cancer and its treatment
There are several breast cancer subtypes. The growth of hormone-dependent breast cancer, the most common subtype, is driven by female hormones. Another common subtype, HER2-positive breast cancer, has excessive copies of a gene called HER2 that makes its cells grow more than they should. Triple-negative breast cancer, also called basal-like breast cancer, is a subtype that isn't affected by hormones or the HER2 gene. It grows rapidly, is more likely to spread beyond the breast… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 4, 2024 Category: Databases & Libraries Source Type: news
A key part of Obamacare is in jeopardy
P are an eccentric lot, but even among them Steven Hotze stands out. The Houston doctor got rich by hawking hormone therapies for all sorts of ills. Motivated by outlandish beliefs—birth control makes women less attractive to men and homosexual activists are “termites” who nibble away at society,…#stevenhotze #houston #bible #obamacare #republicanparty #donaldtrump #republicans #hotze #becerra #fifthcircuit (Source: Reuters: Health)
Source: Reuters: Health - January 1, 2024 Category: Consumer Health News Source Type: news
Research uncovers link between hormone and severe morning sickness during pregnancy
The extent to which women experience morning sickness can vary, and those with extreme nausea and vomiting during pregnancy often face stigma when trying to receive care. While the condition is notoriously understudied, new research is giving hope for better treatment. Amna Nawaz spoke with…#amnanawaz (Source: Reuters: Health)
Source: Reuters: Health - December 30, 2023 Category: Consumer Health News Source Type: news
What ’s In Store For Consumer Healthcare In 2024? Experts Weigh In
Healthcare investors and leaders share their predictions for 2024, from hormonal health and pain management to a broadening focus on women and older consumers, and more. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 29, 2023 Category: Pharmaceuticals Authors: Deb Gordon, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
Science editors pick their most memorable stories of 2023
This year, in late June,
Science
launched our first editorial newsletter:
Science
Adviser
. Every weekday for the past 6 months, newsletter subscribers have received an email packed with the most interesting and important updates from
Science
and science writ large, including exclusive reporting and analysis. (You can
sign up for free
.)
In the giving spirit of the holidays, I—your friendly, neighborhood newsletter editor—let my colleagues take the helm for a day. The editors of News from
Science
selected their favorite stories from the past year, explain...
Source: ScienceNOW - December 29, 2023 Category: Science Source Type: news
What to Know About Heart Failure When You Have Diabetes
In June of 2022, a report from the American Diabetes Association highlighted heart failure as “an underappreciated complication of diabetes.” According to that report, up to 22% of people with diabetes will develop heart failure, and the incidence of heart failure within the diabetes community is increasing.
“Heart failure is the most prevalent cardiovascular complication in people with diabetes,” says Dr. Rodica Pop-Busui, a professor of diabetes at the University of Michigan and president of medicine and science at the American Diabetes Association. “In the U.S. alone there are 37 million...
Source: TIME: Health - December 29, 2023 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news
Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race
THURSDAY, Dec. 28, 2023 -- For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents varies with race, according to a study published online Dec. 1 in JAMA Network Open.
Ting Martin Ma, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2023 Category: Pharmaceuticals Source Type: news
New Insights Into Fibroids Might Lead to Better Treatments
THURSDAY, Dec. 28, 2023 -- Hormone therapy is the usual go-to when women develop painful uterine fibroids, but researchers report they are zeroing in on new avenues for treatment.A University of Cincinnati team found that fibroid cells respond to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 28, 2023 Category: General Medicine Source Type: news
The effect of tennis batting sound on anxiety: a randomized controlled trial and basic acoustic analysis - Wang H, Zhang G, Li X, Pu S.
PURPOSE: To investigate the potential role of the unique sound of tennis in alleviating anxiety. Previous research has consistently shown that exercise can mitigate anxiety, primarily attributed to the impact of increased physical activity on hormonal and ... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Early adverse family experiences and elevated adrenocorticotropic hormone predict non-suicidal self-injury in females with non-psychotic mental disorders and suicidal ideation - Zinchuk MS, Druzhkova TA, Popova SB, Zhanina MY, Guekht AB, Gulyaeva NV.
Nonsuicidal self-injurious behavior (NSSI), prevalent in patients with non-psychotic mental disorders (NPMD), is associated with numerous adverse outcomes. Despite active research into the clinical and psychological aspects of NSSI, the underlying biologic... (Source: SafetyLit)
Source: SafetyLit - December 25, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Consumer Health: What does 'male menopause' mean?
Hormone changes are a natural part of aging, but the experience is different for men and women. Unlike the more dramatic plunge that occurs in women during menopause, sex hormone changes in men occur gradually. This is sometimes called male menopause. For women, menopause marks the end of their menstrual cycles, whether by naturally declining reproductive hormones, surgical removal of the ovaries, changes caused by chemotherapy or radiation therapy, or a conditional called primary ovarian… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 25, 2023 Category: Databases & Libraries Source Type: news
Malpractice Insurance Prices Are Stopping Small Clinics From Offering Gender-Affirming Care to Minors
After Iowa lawmakers passed a ban on gender-affirming care for minors in March, managers of an LGBTQ+ health clinic located just across the state line in Moline, Illinois, decided to start offering that care.
The added services would provide care to patients who live in largely rural eastern Iowa, including some of the hundreds previously treated at a University of Iowa clinic, saving them half-day drives to clinics in larger cities like Chicago and Minneapolis.
[time-brightcove not-tgx=”true”]
By June, The Project of the Quad Cities, as the Illinois clinic is called, had hired a provider who specializes...
Source: TIME: Health - December 21, 2023 Category: Consumer Health News Authors: Cecilia Nowell Tags: Uncategorized LGBTQ Source Type: news
Serum Hormones May Predict AI Benefit for BC Prevention Serum Hormones May Predict AI Benefit for BC Prevention
Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passage
(MedPage Today) -- Healthcare visits for transgender-related diagnoses and gender-affirming hormone therapy (GAHT) have been rising, researchers reported, suggesting it as an opportunity for HIV prevention.
Within a commercial health plan database... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - December 18, 2023 Category: Psychiatry Source Type: news
Hot-flushes menopause drug Veoza approved in UK
Veoza, or fezolinetant, a non-hormonal daily pill, works on the brain's temperature-control centre. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - December 18, 2023 Category: Consumer Health News Source Type: news
